Direct to Patient – Working With Your Investigator Sites & Courier to Create a Successful Partnership (WS5)

1 May 2018
Available Seats:

The attendee will be able to:

  1. Describe two (2) benefits each for the clinical site, sponsor and patient of a direct to patient trial.
  2. Identify at least two (2) risks for sponsors conducting direct to patient trials and develop effective mitigation strategies for these risks.
  3. List no fewer than 3 study characteristics that influence a decision to use a direct to patient strategy and why they should be considered.

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.